Qui Tam

Progress and Deficiencies in the Registration of Clinical Trials

By Marcella Auerbach

The New England Journal of Medicine just recently published an article which raises questions about the ethics and the science of increasingly conducting studies, or clinical trials, outside the United States — when the studies are meant to gather evidence for new drugs to gain approval in this country. The concept certainly raised the issue of whether there is increased clinical trial fraud outside of this country, to the extent there is  less oversight and/or ethics. See Ethical and Scientific Implications of the Globalization of Clinical Research, February 19, 2009.

Full post as published by Pharma 101 - Pharmaceutical Fraud on February 20, 2009 (boomark / email).